BOSTON--(BUSINESS WIRE)--Maxwell Biotech Venture Fund (MBVF), the first Russian venture fund fully dedicated to investments in the life sciences sector, has officially opened its Boston office. Representatives of MBVF will be working at 420 Boylston St. along with colleagues from RVC USA Inc.
